Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Hydroquinone Topical

Phase 3

UUniversity of California, Davis

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Skin PigmentationRecruiting

Skin PigmentationPhase 3

Recruiting

Timeline

Expected Milestones

Q4 2026

ApprovedRecruiting

Skin Pigmentation

NCT04875715

Clinical

Trials by Indication[1]

Skin Pigmentation1 trial

Prospective Evaluation of Topical Almond Oil vs Hydroquinone on the Appearance of Facial Pigmentation and the Stability of the Microbiome

Recruiting·UUniversity of California, Davis·Approved·NCT04875715·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Hydroquinone Topical. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Hydroquinone Topical. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — University of California, Davis company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 3[1]
Company: UUniversity of California, Davis

Related News